Launch
Website- Bupa Platinum consultant
-
Fee assured
-
Awaiting
verification
- Open Referral network
Specialises in
- Breast
- Gynaecology
- Skin
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
I graduated from Barts and the London School of Medicine and Dentistry in 1998, having also obtained an intercalated BSc in Tumour Biology at University College London (1995). After junior medical training in London, including oncology posts at Barts and the Royal Marsden Hospitals, I commenced my Medical Oncology training at Barts before undertaking a PhD in Molecular Oncology and completed my medical oncology training in Wessex. I was appointed as a Consultant in Reading at the Royal Berkshire Hospital in January 2012.
Clinical Involvement
I specialise in the treatment of melanoma, breast and ovarian cancers with systemic treatments. I am also the Acute Oncology Lead for the Thames Valley and the Royal Berkshire Hospitals.
I see private patients at Spire Dunedin Hospital.
As well as my clinical interests, I have an interest in education and am educational supervisor for medical trainees at Royal Berkshire Hospital. In 2015, I edited Challenging Concepts in Oncology, a textbook of clinical scenarios in oncology and recently updated the breast cancer, ovarian cancer and melanoma chapters in the Oxford Handbook of Oncology.
Areas of interest
Breast; Gynaecology; Skin
Medical secretaries
- Marilyn Barras
- 13 Bath Road Reading RG1 6HH
- 0118 955 3538
- 0118 955 3519
- practicemanager@berkshire-oncology.org.uk
- Trish Evans
- Berkshire Oncology Partnership 13 Bath Road Reading RG1 6HH
- 0118 959 8686
- practicemanager@berkshire-oncology.org.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)
Spire Dunedin Hospital (>50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
Spire Dunedin Hospital (>50)
-
S5300
Introduction of substance into skin (including hormone pellet) - (5-50)
Spire Dunedin Hospital (5-50)
-
X3590
Intravenous infusion (as sole procedure) - (1-5)
Spire Dunedin Hospital (1-5)
-
S5210
Injection into subcutaneous tissue/painful trigger point under local anaesthetic - (1-5)
Spire Dunedin Hospital (1-5)